Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Expanding the Phenotype Associated with NAA10 Related N-terminal Acetylation Deficiency.

Saunier C, Støve SI, Popp B, Gérard B, Blenski M, AhMew N, de Bie C, Goldenberg P, Isidor B, Keren B, Leheup B, Lampert L, Mignot C, Tezcan K, Mancini GM, Nava C, Wasserstein M, Bruel AL, Thevenon J, Masurel A, Duffourd Y, Kuentz P, Huet F, Rivière JB, van Slegtenhorst M, Faivre L, Piton A, Reis A, Arnesen T, Thauvin-Robinet C, Zweier C.

Hum Mutat. 2016 Apr 20. doi: 10.1002/humu.23001. [Epub ahead of print]

PMID:
27094817
2.

Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.

Haukaas FS, Arnesen TM, Winje BA, Aas E.

Eur J Health Econ. 2016 Mar 12. [Epub ahead of print]

PMID:
26970772
3.

Tuberculosis outbreak in Eastern Norway.

Arnesen TM, Seterelv S, Norheim G, Helgebostad SR, Mannsåker T, Ly IN, Rønning EJ, Steen TW.

Tidsskr Nor Laegeforen. 2015 Dec 15;135(23-24):2160-4. doi: 10.4045/tidsskr.14.0770. eCollection 2015 Dec 15. English, Norwegian.

4.

NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.

Casey JP, Støve SI, McGorrian C, Galvin J, Blenski M, Dunne A, Ennis S, Brett F, King MD, Arnesen T, Lynch SA.

Sci Rep. 2015 Nov 2;5:16022. doi: 10.1038/srep16022.

5.

Naa10 in development and disease.

Myklebust LM, Støve SI, Arnesen T.

Oncotarget. 2015 Oct 27;6(33):34041-2. doi: 10.18632/oncotarget.5867. No abstract available.

6.

The N-terminal acetyltransferase Naa10 is essential for zebrafish development.

Ree R, Myklebust LM, Thiel P, Foyn H, Fladmark KE, Arnesen T.

Biosci Rep. 2015 Aug 6;35(5). pii: e00249. doi: 10.1042/BSR20150168.

7.

Downregulation of N-terminal acetylation triggers ABA-mediated drought responses in Arabidopsis.

Linster E, Stephan I, Bienvenut WV, Maple-Grødem J, Myklebust LM, Huber M, Reichelt M, Sticht C, Geir Møller S, Meinnel T, Arnesen T, Giglione C, Hell R, Wirtz M.

Nat Commun. 2015 Jul 17;6:7640. doi: 10.1038/ncomms8640.

8.

Holding it together: Naa60 at the Golgi.

Aksnes H, Marie M, Arnesen T.

Oncotarget. 2015 Jun 30;6(18):15726-7. No abstract available.

9.

(Hyper)tension release by N-terminal acetylation.

Aksnes H, Drazic A, Arnesen T.

Trends Biochem Sci. 2015 Aug;40(8):422-4. doi: 10.1016/j.tibs.2015.05.003. Epub 2015 May 28.

PMID:
26027460
10.

N-terminal modifications of cellular proteins: The enzymes involved, their substrate specificities and biological effects.

Varland S, Osberg C, Arnesen T.

Proteomics. 2015 Jul;15(14):2385-401. doi: 10.1002/pmic.201400619. Epub 2015 Jun 16. Review.

11.

N-terminal acetylome analysis reveals the specificity of Naa50 (Nat5) and suggests a kinetic competition between N-terminal acetyltransferases and methionine aminopeptidases.

Van Damme P, Hole K, Gevaert K, Arnesen T.

Proteomics. 2015 Jul;15(14):2436-46. doi: 10.1002/pmic.201400575. Epub 2015 Jun 5.

PMID:
25886145
12.

Molecular, cellular, and physiological significance of N-terminal acetylation.

Aksnes H, Hole K, Arnesen T.

Int Rev Cell Mol Biol. 2015;316:267-305. doi: 10.1016/bs.ircmb.2015.01.001. Epub 2015 Feb 25. Review.

PMID:
25805127
13.

An organellar nα-acetyltransferase, naa60, acetylates cytosolic N termini of transmembrane proteins and maintains Golgi integrity.

Aksnes H, Van Damme P, Goris M, Starheim KK, Marie M, Støve SI, Hoel C, Kalvik TV, Hole K, Glomnes N, Furnes C, Ljostveit S, Ziegler M, Niere M, Gevaert K, Arnesen T.

Cell Rep. 2015 Mar 3;10(8):1362-74. doi: 10.1016/j.celrep.2015.01.053. Epub 2015 Feb 26.

14.

Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects.

Myklebust LM, Van Damme P, Støve SI, Dörfel MJ, Abboud A, Kalvik TV, Grauffel C, Jonckheere V, Wu Y, Swensen J, Kaasa H, Liszczak G, Marmorstein R, Reuter N, Lyon GJ, Gevaert K, Arnesen T.

Hum Mol Genet. 2015 Apr 1;24(7):1956-76. doi: 10.1093/hmg/ddu611. Epub 2014 Dec 8.

15.

De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and females.

Popp B, Støve SI, Endele S, Myklebust LM, Hoyer J, Sticht H, Azzarello-Burri S, Rauch A, Arnesen T, Reis A.

Eur J Hum Genet. 2015 May;23(5):602-9. doi: 10.1038/ejhg.2014.150. Epub 2014 Aug 6.

16.

[The Communicable Diseases Act and coercion].

Steen TW, Arnesen TM.

Tidsskr Nor Laegeforen. 2014 Aug 5;134(14):1371-2. doi: 10.4045/tidsskr.14.0024. eCollection 2014 Aug 5. Norwegian. No abstract available.

17.

[Use of coercion pursuant to the Communicable Diseases Act 1995-2013].

Steen TW, Arnesen TM.

Tidsskr Nor Laegeforen. 2014 Aug 5;134(14):1357-60. doi: 10.4045/tidsskr.14.0023. eCollection 2014 Aug 5. Norwegian.

18.

A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.

Van Damme P, Støve SI, Glomnes N, Gevaert K, Arnesen T.

Mol Cell Proteomics. 2014 Aug;13(8):2031-41. doi: 10.1074/mcp.M113.035402. Epub 2014 Jan 9.

19.

Outbreak of wound botulism in people who inject drugs, Norway, October to November 2013.

MacDonald E, Arnesen TM, Brantsaeter AB, Gerlyng P, Grepp M, Hansen BÅ, Jonsrud K, Lundgren B, Mellegård H, Møller-Stray J, Rønning K, Vestrheim DF, Vold L.

Euro Surveill. 2013 Nov 7;18(45):20630.

20.

Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas.

Dutta RK, Welander J, Brauckhoff M, Walz M, Alesina P, Arnesen T, Söderkvist P, Gimm O.

Endocr Relat Cancer. 2014 Jan 8;21(1):L1-4. doi: 10.1530/ERC-13-0466. Print 2014 Feb. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk